Target intelligence / Profile preview

RNA, U1 small nuclear 94, pseudogene (RNU1-94P)

Target
RNU1-94P
Molecular classification
Other (Pseudogene; processed RNA gene), Small nuclear RNA (snRNA)
01

Overview

RNU1-94P refers to a member of the large family of U1 small nuclear RNA pseudogenes, which are imperfect or variant copies of the canonical U1 small nuclear RNA gene, often termed pseudogenes due to sequence changes, deletions, or insertions that typically prevent the expression of fully functional U1 snRNA[2]. RNU1-94P is a pseudogene corresponding to a variant of the U1 small nuclear RNA gene family. U1 small nuclear RNA (snRNA) is an essential structural RNA component of the spliceosome—a ribonucleoprotein complex responsible for recognizing splice sites and initiating splicing of pre-mRNA in eukaryotic nuclei[1][2][3]. While canonical forms like "RNU1-1" encode functional U1 snRNA, pseudogenes like RNU1-94P generally contain sequence changes or deletions that impair canonical function. Some U1 pseudogenes can still be transcribed and may produce variant snRNAs which, in rare cases, modulate RNA processing in developmentally regulated or cell-specific contexts[2]. However, RNU1-94P itself is not known to encode a functional protein or RNA with a defined biological role, nor is it a receptor, enzyme, transporter, or conventional drug target. Key points: Not a classical drug target: RNU1-94P is a non-coding pseudogene, not a protein, receptor, or enzyme. Function uncertain: Some pseudogenes can affect gene regulation, but RNU1-94P lacks evidence for a defined biological or disease role[2]. Misspelling or missing information: "RNA, U1 small nuclear 94, pseudogene" is an accurate locus name for a pseudogene, but might be misinterpreted as a protein or active therapeutic target, which it is not[2].

Other names
RNU1-94PU1 small nuclear RNA pseudogene 94U1 snRNA pseudogene 94
02

Mechanism of action

Not applicable; no mechanism of drug action established for RNU1-94P.

03

Biological functions

Possible regulation of gene expression at the RNA level (variant U1 snRNAs may modulate pre-mRNA processing, 3′ end formation)[2]No known canonical gene product function (not involved in signal transduction, enzymatic activity, etc.)
04

Disease associations

Potential role inferred in cell-specific RNA processing or differentiation (expression pattern may be developmentally regulated)[2]No direct link to human disease established for RNU1-94P (overall, U1 snRNA variants/pseudogenes can alter gene expression, but disease relevance is uncertain).

Beyond the preview

Go deeper on RNA, U1 small nuclear 94, pseudogene (RNU1-94P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 94, pseudogene (RNU1-94P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call